Ziresovir reduces the severity of respiratory syncytial virus in hospitalized infants
1. Ziresovir, an antiviral drug targeted at respiratory syncytial virus (RSV), was superior to placebo in reducing signs and symptoms ...
Tag: respiratory syncytial virus
#VisualAbstract: Ziresovir Reduces Signs and Symptoms in Hospitalized Infants with Respiratory Syncytial Virus Infection
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
#VisualAbstract: Nirsevimab Reduces Hospitalization for RSV Bronchiolitis
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
RSVpreF vaccine prevents RSV-associated illness in adults aged 60+
1. In this randomized controlled trial, respiratory syncytial virus prefusion F protein-based vaccine (RSVpreF) prevented RSV-associated lower respiratory tract illness ...
RSVpreF vaccine prevents severe RSV-associated illness in infants
1. In this randomized controlled trial, respiratory syncytial virus prefusion F protein−based vaccine (RSVpreF) administered during pregnancy prevented severe RSV ...
RSVpreF vaccine prevents symptomatic respiratory syncytial virus infection
1. In this phase 2a study, the RSVpreF vaccine was effective against symptomatic respiratory syncytial virus (RSV) infection as compared ...
Patient Basics: Respiratory Syncytial Virus (RSV)
RSV (respiratory syncytial virus) is a common virus that infects the nose, throat and lungs. In most older children and ...
RSV positivity associated with reduced serious bacterial infection risk [Classics Series]
Image: PD 1. RSV-positive infants were significantly less likely to have an SBI than those who tested negative (7% vs. ...
Get the app